Sponsor Pipeline

Lei Zheng Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
1
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT05604560 A Neoadjuvant Study of Tislelizumab and SX-682 for Resectable Pancreas Cancer Pancreatic Cancer Active, Not Recruiting
Phase 1
NCT07086768 Dose-Escalation and Dose-Expansion Study of BSI-082 Monotherapy and Combined Therapy in… Solid Tumor Recruiting
Disease Areas
Pancreatic Cancer (1)
Get alerts when Lei Zheng's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free